Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
All articles — 31915 total
Dream Finders Homes heads into October with a striking tension: directors buying the stock persistently on the way down, while short sellers show no sign of backing off at 20.7% of the free float. The insider buying is…
Altimmune enters the final stretch of September with a curious split: its short interest remains one of the heaviest in small-cap biotech, yet the bears have been quietly retreating all week while the stock quietly…
SPCX heads into the final days of September caught in a genuine tug-of-war: short interest at a six-week high, the stock up 7.8% on the week, and neither side showing any sign of capitulating. The short-side story…
AVTX enters the week with one of the most extreme short positioning profiles in small-cap biotech — yet the borrow market tells a notably different story from what the headline short interest figure…
Axsome Therapeutics enters the final weeks of Q3 with a sharp divergence at its core: the Street is turning more constructive on the CNS drug developer, yet options traders have moved to their most defensive posture in…
Wave Life Sciences enters the final stretch of September with a fresh analyst blow and a stock trading near the lower end of a brutal year — a setup where the Street's conviction and the money behind the name are…
XLRE has lost 5.7% over the past month and options traders are now the most cautious they've been in weeks — the clearest tension heading into the final stretch of September. The options market tells the sharpest…
Lumentum Holdings enters the back half of September with a notable internal tension: the stock has climbed 13% over the past month and sits at $945.67, yet short sellers are quietly adding back positions they spent…
CIBR has continued the trend flagged earlier this week — the borrow market that was already tightening is now considerably more stressed, even as the ETF adds another 1.6% on the week to trade near $102.58. The lending…
PayPal heads into the final week of September with a 14% one-month slide to $52.89 sitting in uncomfortable contrast to a short base that is rapidly unwinding — a setup where the bears appear to be losing conviction…
Glaukos Corporation heads into its October 28 quarterly print with a notable disconnect: the Street just got more bullish, but the stock is down 7% on the week. The freshest analyst move sharpens the contrast.…
SHOP is up 14% on the week to $147.74, yet the options market is flashing its most defensive posture in over a year — a divergence that makes this week's setup unusually interesting. The clearest signal comes from…
MDT closed the week at $90.77, down 3.2% on the week and roughly 2.8% over the past month, even as the analyst community raised targets in bulk following the company's most recent earnings print. The disconnect between…
Cloudflare enters the final week of September with a compelling internal contradiction: the stock has gained 21% in a month and 8% in the past week alone, yet the analyst consensus sits at "hold" and at least one firm…
Sunrun heads into the final week of September with an unusual tension at its core: nearly 30% of the float is short, yet options traders have just turned sharply more defensive, and the borrow market remains…
Keysight Technologies enters the final week of September riding its strongest monthly stretch in some time — up 11% on the week and nearly 10% over the past month to close at $347.32 — and the interesting tension here…
Citizens Financial Group enters Q3 earnings season with analysts trimming targets, the stock down sharply on the week, and valuations compressing to levels that leave little room for macro disappointment. The price…
Okta is trading at $196.62 — up 3% on the week and 45% over the past month — and the tension this week is no longer about whether the rally is real, but whether options traders are finally starting to believe it. The…
Viking Therapeutics enters the week after a violent 36% price spike, leaving nearly 20% of its float short and options traders more skittish than at any point in months. The move is impossible to ignore. VKTX closed at…
HUBS finds itself in an unusual spot this week: a wave of analyst upgrades to price targets landing on a stock that just fell nearly 10% in five sessions. The Street activity this week was striking in both its volume…
